Prudential Downgrades Boston Scientific to Neutral

Analyst Robert Faulkner says the Taxus stent recall is clearly not going as he expected

Prudential downgraded Boston Scientific (BSX ) to neutral from overweight.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.